RBC Capital Markets raised its price target on Cameco Corp. (CCO.TO, CCJ) to $160 from $150.

Analyst Andrew D. Wong maintained an Outperform rating on shares of the Canadian uranium company.

"We think uranium market fundamentals remain tight and expect continued improvements in contracting activity and prices through 2026," Wong said in a note to clients.

"We also see accelerating momentum in nuclear new builds, with greater opportunities for new builds and potential to pull-forward business as governments and industries work to accelerate construction," the analyst said.

"We continue to see Cameco as best-positioned within the uranium and nuclear sector to benefit from strong fundamentals, and see potential positive catalysts through 2026."

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)